As expected, our data showed that metformin could only alleviate NAFLD in rats with functional Lepr; whereas metformin promoted the pyroptosis of NAFLD hepatocytes when Lepr was dysfunctional in Lepr-deficient rats. The gene discussed is LEPR; the disease is metabolic dysfunction-associated steatotic liver disease.